메뉴 건너뛰기




Volumn 371, Issue 1-2, 2012, Pages 209-215

Potent selective inhibition of STAT 3 versus STAT 1 by cardiac hormones

Author keywords

Cardiac hormones; Epidermal growth factor; Extracellular signal regulated kinases; Signal transducers and activators of transcription

Indexed keywords

ATRIAL NATRIURETIC FACTOR; KALIURETIC PEPTIDE; LONG ACTING NATRIURETIC PEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NATRIURETIC FACTOR; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; VESSEL DILATOR;

EID: 84868519982     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1437-1     Document Type: Article
Times cited : (10)

References (19)
  • 1
    • 1042302005 scopus 로고    scopus 로고
    • The STATs of cancer: New molecular targets come of age
    • 10.1038/nrc1275
    • Yu H, Jove R (2004) The STATs of cancer: new molecular targets come of age. Nat Rev Cancer 4:450-456
    • (2004) Nat Rev Cancer , vol.4 , pp. 450-456
    • Yu, H.1    Jove, R.2
  • 2
    • 0026770248 scopus 로고
    • Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
    • 1496401 10.1126/science.1496401 1:CAS:528:DyaK38XlsV2jurs%3D
    • Schindler C, Shuai K, Prezioso VR, Darnell JE Jr (1992) Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257:809-813
    • (1992) Science , vol.257 , pp. 809-813
    • Schindler, C.1    Shuai, K.2    Prezioso, V.R.3    Darnell Jr., J.E.4
  • 3
    • 0036782706 scopus 로고    scopus 로고
    • Transcription factors as targets for cancer therapy
    • 12360277 10.1038/nrc906 1:CAS:528:DC%2BD38XnsVGrtbo%3D
    • Darnell JE Jr (2002) Transcription factors as targets for cancer therapy. Nat Rev Cancer 2:740-749
    • (2002) Nat Rev Cancer , vol.2 , pp. 740-749
    • Darnell Jr., J.E.1
  • 4
    • 0034657336 scopus 로고    scopus 로고
    • The role of STATs in transcriptional control and their impact on cellular function
    • 10851045 10.1038/sj.onc.1203476 1:CAS:528:DC%2BD3cXktVGhsb4%3D
    • Bromberg J, Darnell JE Jr (2000) The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19:2468-2473
    • (2000) Oncogene , vol.19 , pp. 2468-2473
    • Bromberg, J.1    Darnell Jr., J.E.2
  • 5
    • 0013689209 scopus 로고    scopus 로고
    • Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-medicated cell growth in vitro
    • 9769331 10.1172/JCI3785 1:CAS:528:DyaK1cXmsFOrs74%3D
    • Grandis J, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, Tweardy DJ (1998) Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-medicated cell growth in vitro. J Clin Investig 102:1385-1392
    • (1998) J Clin Investig , vol.102 , pp. 1385-1392
    • Grandis, J.1    Drenning, S.D.2    Chakraborty, A.3    Zhou, M.Y.4    Zeng, Q.5    Pitt, A.S.6    Tweardy, D.J.7
  • 6
    • 0037699512 scopus 로고    scopus 로고
    • Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small-cell carcinoma cells
    • 12833138 10.1038/sj.onc.1206479 1:CAS:528:DC%2BD3sXkvFSkur8%3D
    • Song L, Turkson J, Karras JG, Jove R, Haura EB (2003) Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small-cell carcinoma cells. Oncogene 22:4150-4165
    • (2003) Oncogene , vol.22 , pp. 4150-4165
    • Song, L.1    Turkson, J.2    Karras, J.G.3    Jove, R.4    Haura, E.B.5
  • 7
    • 33748992592 scopus 로고    scopus 로고
    • Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer
    • 16951221 10.1158/1078-0432.CCR-06-0861 1:CAS:528:DC%2BD28XovF2hu7s%3D
    • Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV (2006) Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Clin Cancer Res 12:5055-5063
    • (2006) Clin Cancer Res , vol.12 , pp. 5055-5063
    • Duan, Z.1    Foster, R.2    Bell, D.A.3    Mahoney, J.4    Wolak, K.5    Vaidya, A.6    Hampel, C.7    Lee, H.8    Seiden, M.V.9
  • 8
    • 0030772458 scopus 로고    scopus 로고
    • STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation
    • 9343414 1:CAS:528:DyaK2sXntVSgtrY%3D
    • Chung J, Uchida E, Grammer TC, Blenis J (1997) STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 17:6508-6516
    • (1997) Mol Cell Biol , vol.17 , pp. 6508-6516
    • Chung, J.1    Uchida, E.2    Grammer, T.C.3    Blenis, J.4
  • 9
    • 47649105292 scopus 로고    scopus 로고
    • Cardiac hormones and urodilatin eliminate up to 86 % of human small-cell lung carcinomas in mice
    • 10.1111/j.1365-2362.2008.01978.x 1:CAS:528:DC%2BD1cXhtVOnu7nP
    • Eichelbaum EJ, Sun Y, Alli AA, Gower WR Jr, Vesely DL (2008) Cardiac hormones and urodilatin eliminate up to 86 % of human small-cell lung carcinomas in mice. Eur J Clin Investig 38:562-570
    • (2008) Eur J Clin Investig , vol.38 , pp. 562-570
    • Eichelbaum, E.J.1    Sun, Y.2    Alli, A.A.3    Gower Jr., W.R.4    Vesely, D.L.5
  • 10
    • 34250172696 scopus 로고    scopus 로고
    • Elimination of up to 80 % of human pancreatic adenocarcinomas in athymic mice by cardiac hormones
    • 17591353 1:CAS:528:DC%2BD2sXnsVSjs70%3D
    • Vesely DL, Eichelbaum EJ, Sun Y, Alli AA, Vesely BA, Luther SL, Gower WR Jr (2007) Elimination of up to 80 % of human pancreatic adenocarcinomas in athymic mice by cardiac hormones. In Vivo 21:445-452
    • (2007) Vivo , vol.21 , pp. 445-452
    • Vesely, D.L.1    Eichelbaum, E.J.2    Sun, Y.3    Alli, A.A.4    Vesely, B.A.5    Luther, S.L.6    Gower Jr., W.R.7
  • 11
    • 37349091248 scopus 로고    scopus 로고
    • Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice
    • 18210743 1:CAS:528:DC%2BD1cXkvVagsA%3D%3D
    • Vesely DL, Vesely BA, Eichelbaum EJ, Sun Y, Alli AA, Gower WR Jr (2007) Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice. In Vivo 21:973-978
    • (2007) Vivo , vol.21 , pp. 973-978
    • Vesely, D.L.1    Vesely, B.A.2    Eichelbaum, E.J.3    Sun, Y.4    Alli, A.A.5    Gower Jr., W.R.6
  • 12
    • 33750741904 scopus 로고    scopus 로고
    • Vessel dilator and kaliuretic peptide inhibit activation of ERK 1/2 in human prostate cancer cells
    • 17094432 1:CAS:528:DC%2BD28Xht1ers7nN
    • Sun Y, Eichelbaum EJ, Wang H, Vesely DL (2006) Vessel dilator and kaliuretic peptide inhibit activation of ERK 1/2 in human prostate cancer cells. Anticancer Res 26:3217-3222
    • (2006) Anticancer Res , vol.26 , pp. 3217-3222
    • Sun, Y.1    Eichelbaum, E.J.2    Wang, H.3    Vesely, D.L.4
  • 13
    • 33845930794 scopus 로고    scopus 로고
    • Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells
    • 17201125 1:CAS:528:DC%2BD2sXpslChtA%3D%3D
    • Sun Y, Eichelbaum EJ, Wang H, Vesely DL (2006) Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells. Anticancer Res 26:4143-4148
    • (2006) Anticancer Res , vol.26 , pp. 4143-4148
    • Sun, Y.1    Eichelbaum, E.J.2    Wang, H.3    Vesely, D.L.4
  • 14
    • 64949193847 scopus 로고    scopus 로고
    • Insulin and epidermal growth factor activation of ERK 1/2 and DNA synthesis is inhibited by four cardiac hormones
    • 1:CAS:528:DC%2BD2sXhtValu7zF
    • Sun Y, Eichelbaum EJ, Wang H, Vesely DL (2007) Insulin and epidermal growth factor activation of ERK 1/2 and DNA synthesis is inhibited by four cardiac hormones. J Cancer Mol 3(4):113-120
    • (2007) J Cancer Mol , vol.3 , Issue.4 , pp. 113-120
    • Sun, Y.1    Eichelbaum, E.J.2    Wang, H.3    Vesely, D.L.4
  • 16
    • 67650925065 scopus 로고    scopus 로고
    • Atrial natriuretic peptide and long-acting natriuretic peptide inhibit Ras in human prostate cancer cells
    • 19528444 1:CAS:528:DC%2BD1MXos1Wnurk%3D
    • Sun Y, Eichelbaum EJ, Lenz A, Skelton WP IV, Wang H, Vesely DL (2009) Atrial natriuretic peptide and long-acting natriuretic peptide inhibit Ras in human prostate cancer cells. Anticancer Res 29:1889-1893
    • (2009) Anticancer Res , vol.29 , pp. 1889-1893
    • Sun, Y.1    Eichelbaum, E.J.2    Lenz, A.3    Skelton, I.V.W.P.4    Wang, H.5    Vesely, D.L.6
  • 17
    • 34249288341 scopus 로고    scopus 로고
    • Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells
    • 17595752 1:CAS:528:DC%2BD2sXmsFygurc%3D
    • Sun Y, Eichelbaum EJ, Wang H, Vesely DL (2007) Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells. Anticancer Res 27:1387-1392
    • (2007) Anticancer Res , vol.27 , pp. 1387-1392
    • Sun, Y.1    Eichelbaum, E.J.2    Wang, H.3    Vesely, D.L.4
  • 18
    • 37349025338 scopus 로고    scopus 로고
    • Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells
    • 18225537 1:CAS:528:DC%2BD1cXlslaluw%3D%3D
    • Sun Y, Eichelbaum EJ, Wang H, Vesely DL (2007) Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells. Anticancer Res 27:3813-3818
    • (2007) Anticancer Res , vol.27 , pp. 3813-3818
    • Sun, Y.1    Eichelbaum, E.J.2    Wang, H.3    Vesely, D.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.